Upcoming Vaccines: Will This Mark The End Of Dengue?

Dengue is a perilous disease that infects approximately 400 million people around the globe, of whom 40,000 succumb to the disease. Considering the consequences of the disease, IIL (Indian Immunologicals Limited) has taken steps in preparing the vaccine. The company has successfully finished the first phase of a clinical trial of its vaccine for dengue. IIL further added that the second and third phases of testing the vaccine’s efficacy will soon start. 

In an interaction with The Hindu Team, the managing director of IIL, K. Anand Kumar, said, “The findings of the first phase have already been published in peer-reviewed journals. We should have completed the trial in December, but it was delayed by a few months. We wanted to release it in early 2026, but now, maybe by mid-2026, we will be ready to release the vaccines.”

He further added, “For dengue, we got the virus strains from the National Institute of Virology. By mid-2026, we may be ready to release the vaccines. We will release the results of the clinical trials.”

Also, read about the Future of Preservation.

Other Vaccines

• The company is also working on the development of a vaccine for the Zika virus, which is fully funded by ICMR (Indian Council of Medical Research). Though the virus is limited to Karnataka and its border areas, it still infects more than 400-500 people annually. 
• The disease spreads if an infected person comes in contact with an infected animal, especially sick or dead money. 
• They also launched the vaccine for Hepatitis A, Havisure, which has been working very well and is in huge demand. 

For more such News and Updates, Follow Healthstive on Linkedin, Instagram and other social media platforms and stay updated.